Paradigm Biocapital Advisors LP

SEC CIK: 0001855655
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

LXEO holding history

Lexeo Therapeutics, Inc. in every 13F filed by Paradigm Biocapital Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LXEO overview All 13F holders of LXEO Full Q2 2026 holdings

Shares (Q2 2026): 4,175,382
Value: $19.4M
% of portfolio: 0.4%
Quarters held: 3; Since Q4 2025

Holdings of LXEO by Paradigm Biocapital Advisors LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	4,175,382	$19.4M	0.4%	−2,008,752−32.5%	Reduced	Holders
Q1 2026	6,184,134	$35.5M	0.7%	+1,420,936+29.8%	Added	Holders
Q4 2025	4,763,198	$47.3M	1.3%	+4,763,198	New	Holders